BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28704779)

  • 1. Circulating miR-128 as a potential diagnostic biomarker for glioma.
    Liang RF; Li M; Yang Y; Wang X; Mao Q; Liu YH
    Clin Neurol Neurosurg; 2017 Sep; 160():88-91. PubMed ID: 28704779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Xu F; Xu L; Wang M; An G; Feng G
    Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of microRNAs as novel biomarkers for glioma detection: a meta-analysis based on 11 articles.
    Qu S; Guan J; Liu Y
    J Neurol Sci; 2015 Jan; 348(1-2):181-7. PubMed ID: 25510379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
    Wu K; Li L; Li S
    Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.
    Ma C; Nguyen HPT; Luwor RB; Stylli SS; Gogos A; Paradiso L; Kaye AH; Morokoff AP
    PLoS One; 2018; 13(2):e0189452. PubMed ID: 29444091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis.
    Wei X; Chen D; Lv T; Li G; Qu S
    Mol Neurobiol; 2016 Jan; 53(1):163-170. PubMed ID: 25416859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of circulating miR-21: An update meta-analysis in various cancers and validation in endometrial cancer.
    Gao Y; Dai M; Liu H; He W; Lin S; Yuan T; Chen H; Dai S
    Oncotarget; 2016 Oct; 7(42):68894-68908. PubMed ID: 27655698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of circulating miRNA-122 for hepatitis B virus and/or hepatitis C virus-associated chronic viral hepatitis.
    Zhou X; Fang S; Wang M; Xiong A; Zheng C; Wang J; Yin C
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31427483
    [No Abstract]   [Full Text] [Related]  

  • 10. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
    Zhang L; Cao D; Tang L; Sun C; Hu Y
    Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
    Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
    Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.
    Li S; Yang X; Yang J; Zhen J; Zhang D
    Clin Exp Med; 2016 Feb; 16(1):29-35. PubMed ID: 25516467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma.
    Zhang R; Pang B; Xin T; Guo H; Xing Y; Xu S; Feng B; Liu B; Pang Q
    Mol Neurobiol; 2016 Apr; 53(3):1452-1460. PubMed ID: 25636684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 as a potential diagnostic biomarker for breast cancer patients: a pooled analysis of individual studies.
    Gao Y; Cai Q; Huang Y; Li S; Yang H; Sun L; Chen K; Wang Y
    Oncotarget; 2016 Jun; 7(23):34498-506. PubMed ID: 27153564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-Based Circulating MicroRNAs are Potential Diagnostic Biomarkers for Leukemia: Result from a Meta-Analysis.
    Xu LH; Guo Y; Zhang XL; Chen JJ; Hu SY
    Cell Physiol Biochem; 2016; 38(3):939-49. PubMed ID: 26938054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of microRNA-126 in the diagnosis of cancers: A systematic review and meta-analysis.
    Yan J; Ma S; Zhang Y; Yin C; Zhou X; Zhang G
    Medicine (Baltimore); 2016 Aug; 95(35):e4644. PubMed ID: 27583885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.
    Imani S; Zhang X; Hosseinifard H; Fu S; Fu J
    Oncotarget; 2017 Apr; 8(14):23177-23187. PubMed ID: 28423566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased circulating microRNA-155 as a potential biomarker for breast cancer screening: a meta-analysis.
    Wang F; Hou J; Jin W; Li J; Yue Y; Jin H; Wang X
    Molecules; 2014 May; 19(5):6282-93. PubMed ID: 24840899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic and prognostic values of microRNA-21 in patients with gastric cancer: a meta-analysis.
    Ren J; Kuang TH; Chen J; Yang JW; Liu YX
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):120-130. PubMed ID: 28121346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.